STOCK COMPARISON
ICL Israel Chemicals vs Corteva: Fair Value & Quality
Both stocks run through our valuation models. Here is how ICL Israel Chemicals (ICL) and Corteva (CTVA) compare, as of Aug 10, 2026.
As of Aug 10, 2026, Fair Value Calculator sees ICL Israel Chemicals as the less overvalued of the two: ICL Israel Chemicals trades at $5.31 versus a fair value of $4.29 (-19%), while Corteva trades at $76.83 versus $27.81 (-64%).
ICL Israel Chemicals
ICL · USD · Materials
-19%
upside to fair value
overvalued
Price$5.31
Fair Value$4.29
Quality50/100
Corteva
CTVA · USD · Materials
-64%
upside to fair value
overvalued
Price$76.83
Fair Value$27.81
Quality71/100
Head-to-head numbers
Green value = the better side for that row (for valuation multiples: lower = cheaper).
ICL Israel ChemicalsCorteva
Valuation
24.0×P/E (TTM)46.3×
0.88×P/S (TTM)3.20×
1.09×P/B2.37×
6.2×EV/EBITDA13.2×
9.44×PEG1.44×
3.8%Dividend yield0.9%
$0.19Dividend per share$0.72
Profitability
4%Net margin7%
12%Operating margin24%
5%Return on equity5%
4%Return on assets4%
Growth
15%Revenue growth (YoY)11%
-10.6%Avg. growth/yr (3Y)-0.1%
7.2%Avg. growth/yr (5Y)4.1%
Balance & size
0.29×Debt / equity0.07×
$7BMarket cap$57B
healthyGrowth qualityhealthy
Even match: 7 to 7 metric wins.
Dash = not meaningfully computable, for example with negative equity.
Quality in detail
The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.
ICL Israel Chemicalsof which business quality 48 · market factors 37
Cortevaof which business quality 69 · market factors 58
ProfitabilityMargins and returns on capital today
29
30
Quality GrowthAre margins and returns improving?
32
48
CashflowEarnings quality: real cash, not paper profit
44
80
Fin. StrengthBalance sheet, leverage, solvency risk
48
74
InvestmentDisciplined investing over empire-building
74
97
Low VolatilityCalm price path (market factor)
54
84
MomentumPrice trend over the last 3–12 months (market factor)
32
45
52W MomentumDistance to the 52-week high (market factor)
26
51
Net IssuanceBuybacks instead of dilution
81
100
What the models say
The median fair value (base case) per model family, each in the currency of its trading venue. Green = above the current price, red = below.
ICL Israel Chemicals
DCF Models$2.79
Earnings-Based$2.84
Dividend Discount$2.11
Multiples$4.49
Asset-Based$3.11
Growth DCF$2.25
Economic Profit$3.37
Growth Earnings$2.33
19 of 23 models see the stock below the current price.
Corteva
DCF Models$50.58
Earnings-Based$30.99
Dividend Discount$9.27
Multiples$35.54
Asset-Based$24.19
Growth DCF$57.96
Economic Profit$34.06
Growth Earnings$21.85
24 of 24 models see the stock below the current price.
Scenario ranges
From our cautious bear case to the optimistic bull case. The white tick is the current price: left of fair value means room to run.
ICL Israel Chemicals
Bear $3.21Fair Value $4.29Bull $5.36
$5.31 = current price (white tick)
Corteva
Bear $20.86Fair Value $27.81Bull $34.76
$76.83 = current price (white tick)
Compare two other stocks
Tap a field and type again, ticker or company name.
Ranked within their sector
Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.
ICL Israel Chemicals · Materials
Quality score50 · above median
Fair value upside-19% · above median
Corteva · Materials
Quality score71 · Top 25%
Fair value upside-64% · bottom 25%
Bottom line
As of Aug 10, 2026, Fair Value Calculator sees ICL Israel Chemicals as the less overvalued of the two: ICL Israel Chemicals trades at $5.31 versus a fair value of $4.29 (-19%), while Corteva trades at $76.83 versus $27.81 (-64%).
Corteva has the higher quality score (71/100).
See the full analysis →
More comparisons
Popular match-ups from the same sectors, all with fair value and quality score.
Free · Top-25 report
See the undervalued quality stocks every month
Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.
A model-based valuation snapshot from 21 models. Values change with price and fundamentals; the date shown above applies.
